Clinical Trial Update: Oral Vancomycin for Secondary Prophylaxis of Clostridium Difficile Infection (CDI) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on oral vancomycin for secondary prophylaxis of recurrent Clostridium difficile infection has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridium Difficile Infection
• Clostridium Difficile Infection Recurrence

Drugs mentioned

• oral vancomycin (vancomycin)

Snippet

Sponsor: University of South Florida | Conditions: Clostridium Difficile Infection, Clostridium Difficile Infection Recurrence | Phase 4 | Status: TERMINATED